earuphoria.
All podcasts
Education · Health · Fitness

NEI Podcast

Neuroscience Education Institute
Rights holder? Report thisneiglobal.libsyn.com

Episodes

November 18, 2026

E295 - 2026 NEI Fall Congress Extended Q&A: Older Adult ADHD, Pediatric ARFID and Anorexia, Glutamatergic Therapies for MDD, and Muscarinic Agonists with Drs. Goodman, Dahlsgaard, Dambrino, and Stahl

This episode features extended Q&A sessions addressing unanswered audience questions from select presentations delivered at the 2026 NEI Fall Congress in Colorado Springs, Colorado: (00:25) No One Is Getting Younger: ADHD in Older Adults by David W. Goodman, MD, DLFAPA (17:59) Under Pressure: Addressing Picky, Restricted, or Disordered Eating in Children and Adolescents by Katherine Dahlsgaard, PhD, ABPP (29:41) Switching Gears in MDD: When, Why, and How to Use Glutamatergic Therapies to Optimize Functional Outcomes by Andrew J. Cutler, MD and Kristian Dambrino, DNP, APRN, PMHNP-BC (44:04) The Clinical Promise of Muscarinic Agonists: Why, When, and How Across Neuropsychiatric Disorders by Stephen M. S...

November 4, 2026

E294 - Busting Myths About Personality Disorders Beyond BPD with Dr. Lois Choi-Kain

In this episode, Dr. Andy Cutler and Dr. Lois Choi-Kain review common myths about personality disorders beyond borderline personality disorder (BPD) and what clinicians may miss when they focus on BPD alone. They discuss dimensional approaches to diagnosis, clinical clues that personality pathology may be present alongside other psychiatric conditions, and how challenges in clinical trials shape the evidence base for treatment. The conversation also explores how to discuss a diagnosis without blame or stigma, the role of medication management, and practical ways to build therapeutic alliance, maintain boundaries, and respond to challenging interpersonal dynamics. Lois Choi-Kain...

October 21, 2026

E293 - New Directions in Treating OCD and Related Disorders with Dr. Jon Grant

In this episode, Dr. Andy Cutler talks with Dr. Jon Grant about how compulsivity presents across obsessive-compulsive disorder (OCD), trichotillomania, and skin-picking disorder (excoriation disorder). They discuss how clinicians can distinguish OCD compulsions from body-focused repetitive behaviors and choose among treatments such as exposure and response prevention, habit-reversal training, medication, and emerging treatment approaches. Jon E. Grant, JD, MD, MPH, is the Ellen C. Manning Professor of Psychiatry and Behavioral Neuroscience at the University of Chicago and co-editor-in-chief of CNS Spectrums. His clinical and research work focuses on the neurobiology and treatment of addictive, impulsive, and compulsive...

October 7, 2026

E292 - Re-release: Wired for Creativity? The Bipolar-Genius Connection with Dr. Tiffany Greenwood

Originally released in 2022, this episode of The PsychopharmaStahlogy Show features Drs. Andrew Cutler and Stephen Stahl in conversation with Dr. Tiffany Greenwood on the genetic and trait-based links between bipolar disorder and creativity. They explore how temperament, personality, and cognitive style may occupy the space between madness and genius, the role of dopamine, evolutionary explanations for why bipolar risk persists, and why stabilizing mood doesn't have to mean losing creativity. Tiffany A. Greenwood, PhD, is an Associate Professor in the Department of Psychiatry at the University of California San Diego. Her research uses dimensional traits to refine...

September 23, 2026

E291 - Re-release: Recognizing and Treating Anhedonia with Dr. Vladimir Maletic

Originally released in 2024, this episode features the late Dr. Vladimir Maletic in conversation with Drs. Andy Cutler and Stephen Stahl about the clinical significance and neurobiology of anhedonia. They discuss its different dimensions, how it differs from emotional blunting, its relationship to functioning and treatment response, and practical approaches to assessment and treatment. The episode highlights why recovery from depression requires restoring interest, motivation, and pleasure—not simply reducing negative symptoms. Vladimir Maletic, MD, MS, was a clinical professor of psychiatry and behavioral science at the University of South Carolina School of Medicine in Greenville and a co...

September 9, 2026

E290 - ADHD and Substance Use Disorders: Treatment Challenges with Dr. Timothy Wilens

In this episode, Dr. Andy Cutler speaks with Dr. Tim Wilens about the complex relationship between attention-deficit/hyperactivity disorder (ADHD) and substance use disorders. They discuss how to distinguish ADHD from substance-related cognitive symptoms, determine when co-occurring conditions should be treated concurrently, and select appropriate ADHD medications based on the substance involved. Dr. Wilens also examines stimulant misuse and diversion, the role of nonstimulants, what is known about centanafadine's abuse potential, and practical approaches to monitoring treatment without undermining the therapeutic relationship. Timothy E. Wilens, MD, is chief of the Division of Child and Adolescent Psychiatry and...

August 26, 2026

E289 - Recognizing and Managing the Biggest Mistakes in Psychopharmacology with Dr. Thomas Schwartz

Originally released in 2021, this episode features Dr. Thomas Schwartz discussing common mistakes in psychopharmacology and how psychiatric clinicians can recognize and manage them. He explores diagnostic uncertainty, medication dosing, informed consent and monitoring, and rational versus irrational polypharmacy. He also considers how clinicians can reassess inherited diagnoses, learn from prescribing errors, and preserve the therapeutic relationship when mistakes occur. Thomas L. Schwartz, MD, is a Distinguished Teaching Professor at Norton College of Medicine, SUNY Upstate Medical University in Syracuse, New York. He is an award-winning educator deeply involved in medical student and resident training, as well as...

August 12, 2026

E288 - PsychopharmaPearls: Kratom—What Clinicians Need to Know with Dr. William Sauvé

In this episode of PsychopharmaPearls, Dr. Andy Cutler and Dr. Will Sauvé discuss what clinicians need to know about kratom. They review why patients use it, signs of misuse, dependence, or withdrawal, and key pharmacologic and safety concerns. The conversation also offers practical guidance for discussing kratom use and incorporating it into treatment planning. William Sauvé, MD, is a board-certified psychiatrist and Chief Medical Officer at Osmind. He has extensive experience in interventional psychiatry, including TMS and esketamine, and previously served for 11 years as an active-duty Navy psychiatrist. He also serves on the faculty of the Neuroscience Ed...

July 29, 2026

E287 - Deprescribing Practices in Psychiatry with Drs. Stephen Stahl and Jeffrey Strawn

In this episode, Dr. Andy Cutler is joined by Drs. Stephen Stahl and Jeffrey Strawn to discuss deprescribing practices in psychiatry. They explore why deprescribing is an essential clinical skill, how to determine whether a patient still needs a medication, dose, or combination, and how to approach tapering in a way that balances relapse prevention, withdrawal risk, and patient-centered care. The conversation also covers practical considerations for deprescribing antidepressants, antipsychotics, benzodiazepines, and sedative-hypnotics, with attention to common pitfalls and strategies for safer, more intentional medication management. Stephen M. Stahl, MD, PhD, DSc (Hon.), is a psychiatrist, psychopharmacologist...

July 15, 2026

E286 - GLP-1 Agonists in Psychiatry: Beyond Weight Loss with Dr. Roger McIntyre

In this episode, Dr. Andy Cutler is joined by Dr. Roger McIntyre to discuss GLP-1 receptor agonists in psychiatry and why these medications may be relevant beyond weight loss. They explore the emerging role of GLP-1s in metabolic psychiatry, including potential connections with mood disorders, cognition, reward pathways, cardiometabolic health, and psychiatric medication-associated weight gain. Dr. McIntyre also discusses what psychiatric providers should know now, where the evidence is still evolving, and what future research is needed before GLP-1 or incretin-based therapies could be considered part of psychiatric treatment. Roger S. McIntyre, MD, FRCPC, is Professor...

July 1, 2026

E285 - Re-release: Eating Disorders, Nutrition, and the Brain with Dr. Cynthia Bulik

Originally released in June 2023, this episode features Dr. Cynthia Bulik in a discussion of eating disorders, nutrition, and the brain. The conversation explores anorexia nervosa, bulimia nervosa, binge eating disorder, ARFID, common misconceptions about eating disorders, and the evolving understanding of how biology, genetics, and environment shape risk, diagnosis, and recovery. Cynthia Bulik, PhD, FAED, is a Distinguished Professor of Eating Disorders in the Department of Psychiatry at the University of North Carolina at Chapel Hill and Professor of Nutrition in the Gillings School of Global Public Health. She is the founding director of the UNC Center...

June 17, 2026

E284 - Nutritional Interventions in Psychiatry: Hype vs. Evidence with Dr. Bhagwan Bahroo

In this episode, Dr. Andy Cutler talks with Dr. Bhagwan Bahroo about nutritional interventions in psychiatry, including diet, supplements, metabolic health, inflammation, and the gut-brain axis. They explore where the evidence is strongest, where hype outpaces the data, and how clinicians can discuss nutritional strategies as adjunctive tools without losing focus on core treatments. Bhagwan A. Bahroo, MD, DLFAPA, is a board-certified psychiatrist in adult, addiction, and forensic psychiatry and an Assistant Professor at the Uniformed Services University of the Health Sciences in Bethesda, Maryland. He has extensive clinical experience at Walter Reed National Military Medical Center...

June 3, 2026

E283 - PsychopharmaPearls: When Akathisia Looks Like Agitation with Dr. Leslie Citrome

In this episode of PsychopharmaPearls, Dr. Andy Cutler talks with Dr. Leslie Citrome about akathisia, a common but often misdiagnosed antipsychotic side effect that can look like agitation, anxiety, irritability, or worsening psychiatric symptoms. They discuss how to recognize akathisia in clinical practice, distinguish it from true agitation, identify key timing and symptom clues, and avoid common treatment mistakes, including why benztropine is not an appropriate treatment for akathisia. Leslie Citrome, MD, MPH, is Clinical Professor of Psychiatry and Behavioral Sciences at New York Medical College and an internationally recognized expert in psychopharmacology and clinical trial interpretation...

May 20, 2026

E282 - 2026 NEI Spring Congress Extended Q&A: Anxiety, Schizophrenia, and Postpartum Mood Disorders with Drs. Strawn, Correll, and Payne

This episode features extended Q&A sessions addressing unanswered audience questions from select presentations delivered at the 2026 NEI Spring Congress in Kissimmee, Florida: (00:53) From Avoidance to Action: Evidence-based Pathways to Recovery for Difficult-to-Treat Anxiety by Jeffrey R. Strawn, MD, FAACAP (15:21) Perhaps the Grass Is Greener: Why, When, and How to Switch or Combine Treatments for Schizophrenia by Christoph U. Correll, MD (34:42) The Other Side of Motherhood: Advances in the Treatment of Postpartum Mood and Anxiety Disorders by Jennifer L. Payne, MD Fall Congress Get $100 off NEI Fall Congress registration...

May 6, 2026

E281 - ADHD, Hormones, or Aging? Sorting Out Cognitive Complaints in Women with Dr. Neill Epperson

In this episode, Dr. Andy Cutler speaks with Dr. Neill Epperson about how to evaluate cognitive complaints in women. They discuss how to differentiate between ADHD, hormonal changes (such as perimenopause), mood and anxiety disorders, and age-related cognitive decline. The conversation highlights key clinical clues, including symptom timing and fluctuation, to improve diagnostic accuracy. Practical strategies for assessment and treatment are reviewed to help clinicians make more informed, individualized decisions. C. Neill Epperson, MD, is the Robert Freedman Endowed Professor and Chair of the Department of Psychiatry at the CU Anschutz School of Medicine. She is an...

April 22, 2026

E280 - PsychopharmaPearls: Managing Rebound Insomnia with Dr. Thomas Schwartz

In this episode, Dr. Andy Cutler speaks with Dr. Thomas Schwartz about insomnia related to antidepressant discontinuation, including how rebound and withdrawal symptoms can emerge when tapering or stopping treatment. They review the underlying mechanisms, clinical risk factors, and how to distinguish discontinuation-related insomnia from relapse of depression or primary sleep disorders. The discussion emphasizes practical, evidence-informed strategies for safely tapering antidepressants and managing sleep disturbance in psychiatric practice. Thomas L. Schwartz, MD, is a Distinguished Teaching Professor at Norton College of Medicine, SUNY Upstate Medical University in Syracuse, New York. He is an award-winning educator deeply...

April 8, 2026

E279 - Sleep in Bipolar Disorder: Clinical Insights with Dr. Holly Swartz

In this episode, Dr. Andy Cutler speaks with Dr. Holly Swartz about the critical role of sleep and circadian rhythms in bipolar disorder, including how sleep disturbance can function as both a symptom and trigger of mood episodes. They discuss how clinicians can better assess sleep to identify early warning signs of relapse, along with practical strategies for intervention, including applying principles of Interpersonal and Social Rhythm Therapy (IPSRT), choosing between behavioral and pharmacologic treatments for insomnia, and avoiding sleep medications that may destabilize mood. The episode offers a clinically focused approach to improving relapse prevention through better sleep...

March 25, 2026

E278 - Re-release: Autism Spectrum Disorder and Comorbidities with Dr. Robyn Thom

In this revisited episode, Dr. Robyn Thom discusses autism spectrum disorder (ASD) and the psychiatric comorbidities that frequently accompany it. She reviews how ASD is diagnosed, the core domains of social communication differences and restricted or repetitive behaviors, and why treatment often focuses on co-occurring conditions such as anxiety, ADHD, sleep disorders, and agitation. Dr. Thom also shares practical strategies for evaluating agitation, distinguishing overlapping symptoms, and selecting behavioral and pharmacologic interventions to support patients with ASD across the lifespan. Robyn Thom, MD, is an Assistant Professor of Psychiatry at Harvard Medical School and a staff psychiatrist...

March 11, 2026

E277 - Shaping Recovery: Early Psychosis Outcomes and Engagement with Dr. Robert Cotes

In this episode, Dr. Andy Cutler talks with Dr. Robert Cotes about optimizing outcomes in early psychosis and why the first episode is a critical window for intervention. They discuss the impact of duration of untreated psychosis, recovery trajectories after a first episode, and what to measure beyond symptom reduction—including functional outcomes, cognition, and relapse risk. The conversation also highlights strategies for engaging young adults and families in coordinated specialty care, early identification of clinical high risk for psychosis, and innovations aimed at improving long-term recovery. Robert O. Cotes, MD, is Professor of Psychiatry and Behavioral Sc...

February 25, 2026

E276 - PsychopharmaPearls: Choosing Ketamine Treatment with Dr. Lisa Harding

PsychopharmaPearls is NEI's focused podcast series highlighting the clinical insights that can sharpen your prescribing decisions. In this episode, Dr. Andy Cutler talks with Dr. Lisa Harding about how to choose between IV ketamine and intranasal esketamine for patients with difficult-to-treat depression. They unpack the differences that truly matter in practice—from patient selection and monitoring to access, cost, and common missteps. Tune in for practical pearls you can immediately apply to select the right treatment for the right patient. Lisa Harding, MD is a board-certified psychiatrist and nationally recognized depression specialist with deep expertise in interventional ps...

Similar podcasts